Veracyte | VCYT - Gross Profit On Sales

Stock Price
36.16
Daily Change
1.30 3.73%
Monthly
-19.84%
Yearly
-12.99%
Q1 Forecast
36.91

Veracyte reported $91.28M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Agilent USD 990M 102M Sep/2025
Arrowhead Research USD 256.47M 228.7M Sep/2025
Bruker USD 379.4M 21.5M Sep/2025
Exact Sciences USD 583.93M 21.48M Sep/2025
Illumina USD 759M 26M Dec/2025
Laboratory Of America USD 1.03B 21.1M Sep/2025
Ligand Pharmaceuticals USD 155.28M 82.42M Sep/2025
Myriad Genetics USD 143.8M 8M Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Siemens EUR 7.54B 132M Jun/2025
Sonic Healthcare AUD 3.92B 3.14B Dec/2024
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Veracyte USD 91.28M 1.51M Sep/2025
Waters USD 459.99M 21.97M Sep/2025